{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:55:15Z","timestamp":1767117315176,"version":"3.37.3"},"reference-count":28,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. Entre el 80 y el 95 % de los pacientes infectados por el virus de inmunodeficiencia humana (HIV) desarrollan manifestaciones en la piel que sirven como marcadores de su estado inmunol\u00f3gico.Objetivos. Describir las manifestaciones dermatol\u00f3gicas y los factores cl\u00ednicos y sociodemogr\u00e1ficos de los pacientes hospitalizados con diagn\u00f3stico de HIV y su correlaci\u00f3n con el recuento de linfocitos T CD4.Materiales y m\u00e9todos. Se hizo un estudio observacional de corte transversal y retrospectivo a partir del registro de las historias cl\u00ednicas de 227 pacientes mayores de edad con diagn\u00f3stico de HIV, evaluados por dermatolog\u00eda en un hospital de Medell\u00edn, Colombia.Resultados. Los 227 registros daban cuenta de 433 manifestaciones dermatol\u00f3gicas, el 64,4 % de ellas infecciosas. Las tres manifestaciones m\u00e1s frecuentes fueron candidiasis oral, condilomas acuminados y reacciones a medicamentos. Se encontr\u00f3 una relaci\u00f3n estad\u00edsticamente significativa entre el virus del herpes z\u00f3ster (HZ) diseminado y la s\u00edfilis secundaria, con un recuento de CD4 entre 200 y 499 c\u00e9lulas\/mm3 (p=0,04 y 0,028, respectivamente), y entre la candidiasis oral y un recuento de CD4 menor de 100 c\u00e9lulas\/mm3 (p=0,008). Conclusiones. La relaci\u00f3n entre el herpes z\u00f3ster diseminado y un recuento de CD4 entre 200 y 499 c\u00e9lulas\/mm3 sugiere que, a pesar de los recuentos altos, se pueden presentar formas graves de la enfermedad debido a una posible disfunci\u00f3n de las c\u00e9lulas T y el agotamiento del sistema inmunol\u00f3gico. La relaci\u00f3n entre la candidiasis oral y un recuento de CD4 menor de 100 c\u00e9lulas\/mm3 plantea la posibilidad de considerar esta infecci\u00f3n mic\u00f3tica como un marcador importante de debilitamiento inmunol\u00f3gico de los pacientes con HIV.<\/jats:p>","DOI":"10.7705\/biomedica.6117","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T17:01:11Z","timestamp":1657731671000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":6,"title":["Manifestaciones mucocut\u00e1neas y su relaci\u00f3n con el recuento de linfocitos T CD4 en pacientes infectados con el virus de inmunodeficiencia humana hospitalizados en Medell\u00edn, Colombia"],"prefix":"10.7705","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-4115","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"San\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-9972","authenticated-orcid":false,"given":"\u00c1ngela Mar\u00eda","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-161X","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-6255","authenticated-orcid":false,"given":"Hern\u00e1n Dar\u00edo","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-5310","authenticated-orcid":false,"given":"Elsa Mar\u00eda","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-2042","authenticated-orcid":false,"given":"Catalina","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5907-7051","authenticated-orcid":false,"given":"Carolina","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"109023","doi-asserted-by":"crossref","unstructured":"Podlipnik S, Morgado-Carrasco D, Alsina-Gibert M. Manifestaciones cut\u00e1neo-mucosas de la infecci\u00f3n por el virus de la inmunodeficiencia humana. Piel. 2016;31:475-84.","DOI":"10.1016\/j.piel.2016.01.013"},{"key":"109024","doi-asserted-by":"crossref","unstructured":"Navarrete-Dechent C, Ortega R, Fich F, Concha M. Manifestaciones dermatol\u00f3gicas asociadas a la infecci\u00f3n por VIH\/SIDA. Rev Chil Infectol. 2015;32:57-71. https:\/\/doi.org\/10.4067\/S0716-10182015000100005","DOI":"10.4067\/S0716-10182015000100005"},{"key":"109025","unstructured":"Chan RKW, Chio MTW, Yi KH. Manifestaciones cut\u00e1neas de infecci\u00f3n por el VIH. En: Callen JP, Cowen EW, Hruza GJ, Jorizzo JL, Lui H, Requena L, et al., editores. Dermatolog\u00eda. Cuarta edici\u00f3n. Madrid: Elsevier; 2019. p. 1364-13. http:\/\/dx.doi.org\/10.1016\/B978-84-9113-365-0.00078-4"},{"key":"109026","doi-asserted-by":"crossref","unstructured":"Tschachler E. The dermatologist and the HIV\/AIDS pandemic. Clin Dermatol. 2014;32:286-9. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.08.012","DOI":"10.1016\/j.clindermatol.2013.08.012"},{"key":"109027","doi-asserted-by":"crossref","unstructured":"Altman K, Vanness E, Westergaard RP. Cutaneous manifestations of human immunodeficiency virus: A clinical update. Curr Infect Dis Rep. 2015;17:9. https:\/\/doi.org\/10.1007\/s11908-015-0464-y","DOI":"10.1007\/s11908-015-0464-y"},{"key":"109028","unstructured":"Maurer TA. Dermatologic manifestations of HIV infection. Top HIV Med. 2005;13:149-54."},{"key":"109029","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Barreneche MF, Restrepo-Castro CA, Hidr\u00f3n-Botero A, Villa-Franco JP, Trompa-Romero IM, Restrepo-Carvajal L, et al. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. AIDS Res Ther. 2017;14:60. https:\/\/doi.org\/10.1186\/s12981-017-0186-3","DOI":"10.1186\/s12981-017-0186-3"},{"key":"109030","unstructured":"Gaviria M, Orozco B, G\u00f3mez LM, Maya C, Estrada S, Pel\u00e1ez LM, et al. Manifestaciones dermatol\u00f3gicas en pacientes con VIH. Seguimiento en 349 pacientes. Revista de la Asociaci\u00f3n Colombiana de Dermatolog\u00eda y Cirug\u00eda Dermatol\u00f3gica. 2007;15:203-7."},{"key":"109031","unstructured":"Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo (CAC). Situaci\u00f3n del VIH en Colombia 2019; Bogot\u00e1: Cuenta de Alto Costo; 2020. Fecha de consulta: 21 de octubre de 2020. Disponible en: https:\/\/cuentadealtocosto.org\/site\/publicaciones\/situaciondel-vih-sida-en-colombia-2019\/?1618436174502"},{"key":"109032","doi-asserted-by":"crossref","unstructured":"Titou H, Ebongo C, Hjira N. Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status. Int J Dermatol. 2018;57:156-61. https:\/\/doi.org\/10.1111\/ijd.13864","DOI":"10.1111\/ijd.13864"},{"key":"109033","doi-asserted-by":"crossref","unstructured":"Todd G. Adverse cutaneous drug eruptions and HIV: A clinician\u2019s global perspective. Dermatol Clin. 2006;24:459-72. https:\/\/doi.org\/10.1016\/j.det.2006.06.008","DOI":"10.1016\/j.det.2006.06.008"},{"key":"109034","doi-asserted-by":"crossref","unstructured":"Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-4. https:\/\/doi.org\/10.1056\/NEJM199306103282304","DOI":"10.1056\/NEJM199306103282304"},{"key":"109035","doi-asserted-by":"crossref","unstructured":"Yang C, Mosam A, Mankahla A, Dlova N, Saavedra A. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. J Am Acad Dermatol. 2014;70:1096-102. https:\/\/doi.org\/10.1016\/j.jaad.2013.12.025","DOI":"10.1016\/j.jaad.2013.12.025"},{"key":"109036","doi-asserted-by":"crossref","unstructured":"Reynaud-Mendel B, Janier M, Gerbaka J, Hakim C, Rabian C, Chastang C, et al. Dermatologic findings in HIV-1-infected patients: A prospective study with emphasis on CD4+ cell count. Dermatology. 1996;192:325-8. https:\/\/doi.org\/10.1159\/000246404","DOI":"10.1159\/000246404"},{"key":"109037","doi-asserted-by":"crossref","unstructured":"Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV\/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007;46:14-8. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03349.x","DOI":"10.1111\/j.1365-4632.2007.03349.x"},{"key":"109038","doi-asserted-by":"crossref","unstructured":"Singh H, Singh P, Tiwari P, Dey V, Dulhani N, Singh A. Dermatological manifestations in HIVinfected patients at a tertiary care hospital in a tribal (Bastar) region of Chhattisgarh, India. Indian J Dermatol. 2009;54:338. https:\/\/doi.org\/10.4103\/0019-5154.57609","DOI":"10.4103\/0019-5154.57609"},{"key":"109039","unstructured":"Altunta\u015f Aydin \u00d6, Kumbasar Karaosmano\u011flu H, Korkusuz R, \u00d6zeren M, \u00d6zcan N. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among"},{"key":"109040","doi-asserted-by":"crossref","unstructured":"Turkish HIV\/AIDS patients in Istanbul, Turkey. Turk J Med Sci. 2015;45:89-92. https:\/\/doi.org\/10.3906\/sag-1308-3","DOI":"10.3906\/sag-1308-3"},{"key":"109041","doi-asserted-by":"crossref","unstructured":"Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: A note on 120 cases. Int J Dermatol. 2004;43:265-8. https:\/\/doi.org\/10.1111\/j.1365-4632.2004.01649.x","DOI":"10.1111\/j.1365-4632.2004.01649.x"},{"key":"109042","doi-asserted-by":"crossref","unstructured":"Fernandes MS, Bhat RM. Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count. Int J STD AIDS. 2015;26:414-9. https:\/\/doi.org\/10.1177\/0956462414543121","DOI":"10.1177\/0956462414543121"},{"key":"109043","doi-asserted-by":"crossref","unstructured":"Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984;311:354-8. https:\/\/doi.org\/10.1056\/NEJM198408093110602","DOI":"10.1056\/NEJM198408093110602"},{"key":"109044","doi-asserted-by":"crossref","unstructured":"Engels EA, Rosenberg PS, Biggar RJ, the District of Columbia Gay Cohort Study, the Multicenter Hemophilia Cohort Study. Z\u00f3ster incidence in human immunodeficiency virus\u2013infected hemophiliacs and homosexual men, 1984-1997. J Infect Dis. 1999;180:1784-9. https:\/\/doi.org\/10.1086\/315146","DOI":"10.1086\/315146"},{"key":"109045","doi-asserted-by":"crossref","unstructured":"Veenstra J, Krol A, van Praag RME, Jos Frissen PM, Schellekens PThA, Lange JMA, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection: AIDS. 1995;9:1153-8. https:\/\/doi.org\/10.1097\/00002030-199510000-00006","DOI":"10.1097\/00002030-199510000-00006"},{"key":"109046","doi-asserted-by":"crossref","unstructured":"Buchbinder SP, Katz MH, Hessol NA, Liu JY, O\u2019Malley PM, Underwood R, et al. Herpes z\u00f3ster and human immunodeficiency virus infection. J Infect Dis. 1992;166:1153-6. https:\/\/doi.org\/10.1093\/infdis\/166.5.1153","DOI":"10.1093\/infdis\/166.5.1153"},{"key":"109047","doi-asserted-by":"crossref","unstructured":"Lidhoo P, Unemori P, Leslie KS, Maurer T. Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients. J Am Acad Dermatol. 2009;61:345-7. https:\/\/doi.org\/10.1016\/j.jaad.2008.11.891","DOI":"10.1016\/j.jaad.2008.11.891"},{"key":"109048","doi-asserted-by":"crossref","unstructured":"Monge-Maillo B, Norman FF, Cruz I, Alvar J, L\u00f3pez-V\u00e9lez R. Visceral leishmaniasis and HIV coinfection in the Mediterranean region. PLoS Negl Trop Dis. 2014;8:e3021. https:\/\/doi.org\/10.1371\/journal.pntd.0003021","DOI":"10.1371\/journal.pntd.0003021"},{"key":"109049","doi-asserted-by":"crossref","unstructured":"Okwor I, Uzonna JE. The immunology of Leishmania\/HIV co-infection. Immunol Res. 2013;56:163-71. https:\/\/doi.org\/10.1007\/s12026-013-8389-8","DOI":"10.1007\/s12026-013-8389-8"},{"key":"109050","doi-asserted-by":"crossref","unstructured":"Chena L, Nara E, Canese A, Aguilar G, Araujo P, Taboada A, et al. Coinfecci\u00f3n Leishmania infantum, VIH e Histoplasma capsulatum: manifestaciones dermatol\u00f3gicas. Mem Inst Investig Cienc Salud. 2016;14:121-5.","DOI":"10.18004\/mem.iics\/1812-9528\/2016.014(03)121-125"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6117\/5038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6117\/5038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T20:20:27Z","timestamp":1660249227000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6117","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"type":"electronic","value":"2590-7379"},{"type":"print","value":"0120-4157"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"2022-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}